IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 3,625.00
+45.00 (1.26%)
Jul 1, 2026, 10:50 AM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 50.18 billion as of June 30, 2026. Its market cap has decreased by -58.99% in one year.
Market Cap
50.18B
Enterprise Value
31.22B
Revenue
5.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,625.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 50.18B, a decrease of -90.04%. That is a compound annual growth rate of -64.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 50.18B | -63.80% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 119.54B |
| MedPacto | 109.34B |
| Amicogen | 104.34B |
| ENCell | 90.11B |
| iNtRON Biotechnology | 82.99B |
| Prestige BioPharma | 81.01B |
| CG Invites | 76.89B |
| ORIENT BIO | 51.52B |